ICU Medical vs Merit Medical Systems
ICUI and MMSI side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How ICUI and MMSI compare
Merit Medical Systems is the larger company, worth 1.2 times as much as ICU Medical ($5.3B against $4.5B).
On earnings, Merit Medical Systems is cheaper: it trades at 33.1× trailing earnings, against 74.0× for ICU Medical.
Merit Medical Systems grew revenue faster over the last twelve months (9.1% versus −5.9% for ICU Medical).
Merit Medical Systems keeps more of each dollar of sales as profit, with a net margin of 9.9% compared with 2.8% at ICU Medical.
Merit Medical Systems scores higher on the StockData Score (13 against 9 for ICU Medical), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | ICUI | MMSI |
|---|---|---|
| Size and price | ||
| Market cap | $4.5B | $5.3B |
| Share price | $178.26 | $88.07 |
| Change, 1 year | 28.0% | −0.29% |
| Change, 5 years | −27.8% | 27.1% |
| Beta (5Y) | 1.00 | 0.69 |
| Employees | 13K | 7,500 |
| StockData Score | ||
| Total score | 9 | 13 (better) |
| Valuation score | 2 | 4 (better) |
| Growth score | 2 | 2 |
| Performance score | 3 | 3 |
| Health score | 2 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/E | 74.0× | 33.1× (better) |
| P/S | 2.0× (better) | 3.3× |
| P/B | 2.0× (better) | 3.0× |
| EV/EBITDA | 17.1× | 16.1× (better) |
| P/FCF | 21.4× (better) | 25.9× |
| PEG | – | 1.82 |
| FCF yield | 4.7% (better) | 3.9% |
| Fair value | $134.86 | $93.00 |
| Margin of safety | −32.2% | 5.3% (better) |
| Growth | ||
| Revenue growth (TTM) | −5.9% | 9.1% (better) |
| Revenue growth, 5Y average | 11.9% (better) | 9.5% |
| Net income growth (TTM) | – | 35.2% |
| EPS growth (TTM) | – | 36.4% |
| EPS growth, 5Y average | −62.5% | – |
| Profitability | ||
| Gross margin | 40.3% | 49.4% (better) |
| Operating margin | 5.1% | 13.5% (better) |
| Net margin | 2.8% | 9.9% (better) |
| FCF margin | 9.6% | 12.6% (better) |
| Return on equity | 2.8% | 9.8% (better) |
| Return on invested capital | 3.6% | 8.5% (better) |
| Financial health | ||
| Debt / equity | 0.53 | 0.42 (better) |
| Net debt / EBITDA | 2.74 | 0.68 (better) |
| Interest coverage | 1.4× | 6.7× (better) |
| Current ratio | 2.37 | 4.52 (better) |
| Altman Z-score | 2.66 | 4.31 (better) |
| Piotroski F-score | 6 | 7 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −0.42% |
| Shareholder yield | 0.00% (better) | −0.42% |
| Ownership | ||
| Held by institutions | 104% | 105% |
| Held by insiders | 1.8% | 2.7% |
| Insider net buying, 12 months | −$7.5M | −$2.7M (better) |
| Short interest, % of float | 6.8% | 6.9% |
Go deeper
- ICUI stock overview
- ICUI income statement
- ICUI valuation and score
- MMSI stock overview
- MMSI income statement
- MMSI valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.